CHM and Parkinson disease: One of the largest studies to explore the impact of SNCA polymorphisms on cognitive decline analyzed the role of REP1 and 19 additional haplotype-tagging SNPs in 922 PD patients from the Molecular Epidemiology of Parkinson’s Disease study.